| Nov 6 |
Novo Nordisk Q3 earnings: Wegovy sales soar 79% year-over-year
|
| Nov 6 |
Wegovy sales are slaying for Novo Nordisk right now
|
| Nov 6 |
Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand
|
| Nov 6 |
Novo Nordisk CFO says 2025 sales could see high-teens percentage growth
|
| Nov 6 |
Novo Nordisk Stock Slips as Sales Grow Less Than Expected
|
| Nov 6 |
Novo beats Eli Lilly in Q3 sales for obesity drug
|
| Nov 6 |
Novo Nordisk: Q3 Earnings Snapshot
|
| Nov 6 |
What can't Ozempic and other weight loss drugs cure?
|
| Nov 6 |
Novo Nordisk aware of 10 deaths related to weight-loss drug copies - report
|
| Nov 6 |
Novo Nordisk reports Q3 results
|
